HIV sero-discordance is a condition in which one partner is HIV-positive while the other is HIV-negative. The seronegative partner is at great risk of infection. The majority of discordant couples are of reproductive age; hence, safe conception interventions is key. Pre-exposure prophylaxis (PrEP) is an HIV prevention strategy that is used to prevent infection of the seronegative partners. This strategy involves antiretroviral drugs that are used before a person gets exposed to the risk of infection with HIV. For complete protection against HIV transmission among the sero-discordant couples, daily adherence to oral intake of PrEP is required. However, adherence to the daily intake of Pre-exposure prophylaxis has been noted to be irregular among the sero-discordant couples hence, endangering the safety of the seronegative partner. The specific objectives were to assess the current adherence status to PrEP. Two coefficients of healthcare provider related barriers; provider’s willingness PrEP (β = -0.098, t = -0.391, Sig. = 0.697), and whether education of clients (β = -0.120, t = -0.467, Sig. = 0.642) were not statistically significant, hence healthcare provider related barriers did not affect the adherence to PrEP.
No takes yet. Share an insight, caveat, or question.
Odongo et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: